Navigation Links
Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
Date:9/6/2007

DETROIT, Sept. 6 /PRNewswire/ -- A story in today's Detroit Free Press incorrectly reported that Blue Cross Blue Shield of Michigan has begun paying for generic Prilosec(R) and said it was the first time the company has paid for generic drugs.

In fact, Blue Cross Blue Shield of Michigan has had an award-winning campaign promoting the use of generic drugs for many years. Since 2001 the company has saved $500 million by promoting generics.

On September 5, the company did announce that it was paying for an over- the-counter drug for the first time, which apparently caused the confusion.

BCBSM is paying for over-the-counter Prilosec and is encouraging a switch to Prilosec OTC for eligible members using the prescription drug Nexium(R) for heartburn and acid reflux disease. The new benefit applies to approximately 1.5 million BCBSM members whose customer groups have agreed to the new program. Not all customer groups have agreed, and members should check with their benefits administrator to confirm their employer's participation, and with their physician to confirm whether the switch is right for them.

The switch will save out-of-pocket costs for eligible Blues members, and member out-of-pocket savings may total $9 million overall, according to Blues estimates. Eligible Blues members switching to Prilosec OTC or the generic version of Prilosec from Nexium will pay nothing for the first prescription/supply of the drug, and they only will pay their normal generic drug copayment for subsequent prescriptions.

Members should check with their benefits administrator to confirm their employer's participation, and with their physician to confirm whether the switch is right for them. This is the latest in a series of efforts by BCBSM to identify and encourage ways that Blues members can continue to receive quality health care at lower costs.

The savings for each member will depend on several variables, including their copayment levels and frequency of use. A Blues member whose monthly copayment is $10 for a generic drug and $20 for a brand name drug could save around $130 a year using Prilosec OTC or generic Prilosec instead of Nexium. The savings are calculated on the basis of a year's supply of a brand name drug.

Employers in the program could save nearly $20 million in aggregate drug ingredient costs in the first year, helping slow the growth of prescription drug cost trends. Nexium is one of the most widely-prescribed drugs.

A full news release is available at bcbsm.com.

Blue Cross Blue Shield of Michigan is nonprofit and an independent licensee of the Blue Cross and Blue Shield Association.


'/>"/>
SOURCE Blue Cross Blue Shield of Michigan
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Flu-Drugs Are Causing Resistance Across The World
4. Encephalitis Death Toll In U.P. Crosses 200 Mark.
5. Encephalitis Deaths Cross 220 in Uttar Pradesh
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: